Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19810040 | 0.95 | CYP1A2 (0.46) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL30376019 | 0.95 | MEN1 (0.48) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL8662572 | 0.95 | MEN1 (0.48) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL19810032 | 0.95 | MEN1 (0.48) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| Anthracene SCHEMBL2876495 | 0.92 | CYP3A4 (0.50) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL31274423 | 0.89 | MEN1 (0.52) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL7914941 | 0.89 | MEN1 (0.52) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL29604701 | 0.89 | MEN1 (0.52) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL1808685 | 0.89 | MEN1 (0.52) | MEN1KMT2ACYP3A4TSHRHSD17B10 | |
| SCHEMBL19810068 | 0.83 | ESR1 (0.43) | MEN1KMT2ACYP3A4TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10604469-B2 | Method for the preparation of a partially hydrogenated polyacene and an intermediate thereof | FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA (ES) | 2020-03-31 | — | — | US | disclosed |
| US-20190161426-A1 | METHOD FOR THE PREPARATION OF A PARTIALLY HYDROGENATED POLYACENE AND AN INTERMEDIATE THEREOF | UNIVERSITAT ROVIRA I VIRGILI (ES) | 2019-05-30 | — | — | US | disclosed |
| WO-2018019436-A1 | METHOD FOR THE PREPARATION OF A PARTIALLY HYDROGENATED POLYACENE AND AN INTERMEDIATE THEREOF | FUNDACIÓ INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (ICIQ) (ES) | 2018-02-01 | — | — | WO | disclosed |
| EP-3275876-A1 | METHOD FOR THE PREPARATION OF A PARTIALLY HYDROGENATED POLYACENE AND AN INTERMEDIATE THEREOF | Fundació Institut Català D'investigació Quimica (ES) | 2018-01-31 | — | — | EP | disclosed |
| US-8785671-B2 | 6,13-dihalogen-5,14-dihydropentacene derivative and method for producing 6,13-substituted-5,14-dihydropentacene derivative using same | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20130079530-A1 | 6,13-DIHALOGEN-5,14-DIHYDROPENTACENE DERIVATIVE AND METHOD FOR PRODUCING 6,13-SUBSTITUTED-5,14-DIHYDROPENTACENE DERIVATIVE USING SAME | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY | 2013-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079530-A1 | 6,13-DIHALOGEN-5,14-DIHYDROPENTACENE DERIVATIVE AND METHOD FOR PRODUCING 6,13-SUBSTITUTED-5,14-DIHYDROPENTACENE DERIVATIVE USING SAME | DHCR7, DHCR24, DHPS | MEN1 1611/4885KMT2A 1267/4885CYP3A4 182/4885 |
| US-10604469-B2 | Method for the preparation of a partially hydrogenated polyacene and an intermediate thereof | PARN, PCBP1, PARG | MEN1 973/4885KMT2A 528/4885CYP3A4 584/4885 |
| US-20190161426-A1 | METHOD FOR THE PREPARATION OF A PARTIALLY HYDROGENATED POLYACENE AND AN INTERMEDIATE THEREOF | PARN, PCBP1, PARG | MEN1 973/4885KMT2A 528/4885CYP3A4 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.